Gelteq Limited (NASDAQ:GELS) Short Interest Update

Gelteq Limited (NASDAQ:GELS) was the target of a significant decrease in short interest in the month of January. As of January 30th, there was short interest totaling 130,041 shares, a decrease of 87.0% from the January 15th total of 1,003,425 shares. Currently, 1.4% of the company’s shares are sold short. Based on an average trading volume of 181,231 shares, the days-to-cover ratio is presently 0.7 days. Based on an average trading volume of 181,231 shares, the days-to-cover ratio is presently 0.7 days. Currently, 1.4% of the company’s shares are sold short.

Analyst Ratings Changes

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Gelteq in a report on Monday, December 29th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, Gelteq has a consensus rating of “Sell”.

Gelteq Price Performance

GELS traded down $0.01 during trading on Tuesday, reaching $0.80. 11,591 shares of the company’s stock were exchanged, compared to its average volume of 3,028,034. The company’s fifty day moving average price is $0.95 and its 200-day moving average price is $1.17. Gelteq has a fifty-two week low of $0.67 and a fifty-two week high of $4.11.

Institutional Investors Weigh In On Gelteq

An institutional investor recently bought a new position in Gelteq stock. Susquehanna International Group LLP bought a new stake in Gelteq Limited (NASDAQ:GELS) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 41,550 shares of the company’s stock, valued at approximately $57,000. Susquehanna International Group LLP owned 0.44% of Gelteq at the end of the most recent quarter.

Gelteq Company Profile

Gelteq Inc is a biotechnology company which specializes in the formulation, development and manufacturing of ingestible gel platform designed for nutrient and drug delivery. The Company is focused on advancing and commercializing its delivery solutions within core verticals pharmaceuticals, over-the-counter medications, nutraceuticals, animal medications and sports nutrition. Gelteq Inc is based in NEW YORK.